Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB056A | — |
INCORRECT PREPARATION; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 12-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB056A, expiry date 31-AUG-2025) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced incomplete dose administered (Verbatim: INCORRECT PREPARATION). The outcome of the incomplete dose administered was not applicable. Additional Information: GSK Receipt Date: 19-AUG-2025 The reporter was reported regarding Menveo, specifically the Menveo kids so, they had a kind of a situation right now where while they were doing their monthly inventory of our vaccines they ended up with one powder vial which told that group of five did not get fully vaccinated. The question was because they did want to revaccinate all five patients because they did not know which of the five received the incomplete vaccine, so, what was the timeframe for them to revaccinate a 12 years old.